Ken Robbins

478 citations
8 papers · 371 · h-index 6

Impact in

  • Hepatology top 2%
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Oncology top 10%
    • Colorectal Cancer Treatments and Studies
    • Pancreatic and Hepatic Oncology Research
    • Lung Cancer Research Studies

Papers in

    • Hepatocellular Carcinoma Treatment and Prognosis 7
    • Colorectal Cancer Treatments and Studies 2
    • Pancreatic and Hepatic Oncology Research 2
    • Lung Cancer Research Studies 2
    • Cancer Treatment and Pharmacology 1

Ken Robbins

8 papers receiving 367 citations

Peers

Ken Robbins
Comparison fields: 5 of 28
  • Hepatology 332
  • Oncology 257
  • Pulmonary and Respiratory Medicine 137
  • Surgery 133
  • Radiology, Nuclear Medicine and Imaging 34
Replace Dana Tomalty with:
Dana Tomalty United States
Luca Mulazzani Italy
Paolo Coschiera Italy
Julien Leporrier France
Giuseppe Cardaci Australia
Wendy Langeberg United States
Ermanno Notarianni Italy
Julie N. Leal United States
P Ségol France
C B Wood United Kingdom
Ken Robbins relative to Dana Tomalty United States Dana Tomalty's profile →
Citations per field
00.5×1.5×
Dana Tomalty · 1×
Citations per year

Countries citing papers authored by Ken Robbins

Since Specialization
Citations

This map shows the geographic impact of Ken Robbins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Robbins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Robbins more than expected).

Fields of papers citing papers by Ken Robbins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Robbins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Robbins. The network helps show where Ken Robbins may publish in the future.

Co-authors

The 11 scholars most cited alongside Ken Robbins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ken Robbins Line = papers co-authored together Ken Robbins links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1 2010151
2 200980
3 200965
4 201037
5 201126
6 201210
7 20121
8
Building a house
19841

About Ken Robbins

Ken Robbins is a scholar working on Hepatology, Oncology, Surgery, Pulmonary and Respiratory Medicine and Infectious Diseases, having authored 8 papers that have together received 371 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Colorectal Cancer Treatments and Studies (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Lung Cancer Treatments and Mutations (2 papers), Lung Cancer Research Studies (2 papers), Cancer Treatment and Pharmacology (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Hepatology (332 citations), Oncology (257 citations), Pulmonary and Respiratory Medicine (137 citations), Surgery (133 citations) and Radiology, Nuclear Medicine and Imaging (34 citations). Ken Robbins has collaborated with scholars based in United States, Czechia and Spain. Frequent co-authors include Robert C.G. Martin, Dana Tomalty, Cliff Tatum, Miloslav Roček, Radek Pádr, Ryan O’Hara, Petar Bošnjaković, Matthew Bower, Tomáš Andrašina and Ricardo García Mónaco. Their work appears in journals such as Journal of Oncology, World Journal of Surgical Oncology, Annals of Surgical Oncology, Breast Cancer Research and Treatment and HPB.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact